Aveanna Healthcare (NASDAQ:AVAH) Insider Sells $98,974.04 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 11,839 shares of the stock in a transaction on Tuesday, December 30th. The shares were sold at an average price of $8.36, for a total transaction of $98,974.04. Following the completion of the sale, the insider directly owned 317,530 shares of the company’s stock, valued at approximately $2,654,550.80. This trade represents a 3.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $8.08 on Monday. The firm’s 50-day moving average is $8.92 and its 200-day moving average is $7.52. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $450.53 million for the quarter. Equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Institutional Trading of Aveanna Healthcare

Several hedge funds have recently modified their holdings of the company. Jump Financial LLC bought a new position in shares of Aveanna Healthcare in the first quarter valued at approximately $59,000. Walleye Capital LLC raised its position in Aveanna Healthcare by 268.9% in the 1st quarter. Walleye Capital LLC now owns 51,470 shares of the company’s stock valued at $279,000 after purchasing an additional 37,517 shares during the last quarter. MetLife Investment Management LLC raised its position in Aveanna Healthcare by 16.2% in the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after purchasing an additional 4,349 shares during the last quarter. AQR Capital Management LLC boosted its stake in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after purchasing an additional 4,602 shares in the last quarter. Finally, Banque Transatlantique SA bought a new stake in shares of Aveanna Healthcare during the first quarter worth $25,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on AVAH shares. BMO Capital Markets initiated coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price objective for the company. Jefferies Financial Group increased their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. UBS Group raised their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research note on Friday, November 7th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price objective for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $10.69.

Key Stores Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi?million?share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short?term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.